There is growing evidence that chronic IFN-γ signaling inhibits T cell diversity to restrict anti-tumor immunity, while the inhibition of IFN-γ signaling leads to phenotypically less exhausted TILs, but impaired ICP inhibition [12]. Here, IFNG is linked to neoplasm.